Can Methylprednisoloneacetate Prevent Seroma After Mastectomy for Primary Breast Cancer
Status:
Unknown status
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
A randomised double-blinded study, in which the patients either get methylprednisoloneacetate
or saline solution in the mastectomy cavity to evaluate the efficacy of
methylprednisoloneacetate in preventing seroma in patients operated for primary breast
cancer.